Revolade 25 mg Tablet – Buy Online

Introduction to Revolade 25 mg

Revolade 25 mg is a prescription medication primarily used in the management of certain blood-related disorders associated with low platelet counts. The tablet contains Eltrombopag Olamine as its active ingredient, a medicine that helps stimulate the production of platelets in the bone marrow. Platelets play a crucial role in blood clotting, and insufficient platelet levels may increase the risk of excessive bleeding and bruising.

Revolade 25 mg is prescribed for specific medical conditions where platelet production is impaired or reduced. Treatment should always be carried out under the supervision of a qualified healthcare professional who can monitor the patient's response and adjust therapy when necessary.

Active Ingredient

Eltrombopag Olamine

Eltrombopag belongs to a class of medicines known as thrombopoietin receptor agonists. These medications are designed to stimulate platelet production by activating receptors involved in the body's natural platelet-forming process.

Product Information

• Brand Name: Revolade 25 mg

• Generic Name: Eltrombopag Olamine

• Strength: 25 mg

• Dosage Form: Oral Tablet

• Drug Class: Thrombopoietin Receptor Agonist

How Revolade 25 mg Works

The human body continuously produces platelets within the bone marrow. In some medical conditions, platelet production becomes inadequate, resulting in a low platelet count. Revolade 25 mg works by binding to thrombopoietin receptors found on bone marrow cells.

This stimulation encourages the bone marrow to increase platelet production. As platelet levels rise, the body's ability to form blood clots may improve, helping reduce the likelihood of bleeding complications associated with thrombocytopenia.

Unlike platelet transfusions, which provide a temporary increase in platelet levels, Revolade works by supporting the body's own platelet production mechanisms.

Medical Uses of Revolade 25 mg

Chronic Immune Thrombocytopenia (ITP)

Revolade 25 mg may be prescribed for patients with chronic immune thrombocytopenia, a condition in which the immune system mistakenly attacks and destroys platelets.

Severe Aplastic Anemia

The medication may be used in selected patients with severe aplastic anemia when blood cell production by the bone marrow is significantly reduced.

Hepatitis C-Associated Thrombocytopenia

In certain cases, Revolade may help improve platelet counts in patients with chronic hepatitis C who experience thrombocytopenia that may interfere with treatment plans.

The specific indication depends on the patient's medical history, laboratory findings, and physician recommendations.

Key Characteristics of Revolade 25 mg

Supports Platelet Production

The medicine promotes the body's natural ability to generate platelets through bone marrow stimulation.

Oral Administration

Revolade is available as an oral tablet, eliminating the need for injections in many treatment situations.

Long-Term Management Option

For some patients, Revolade may form part of an ongoing treatment strategy to maintain healthier platelet levels.

Targeted Mechanism of Action

Rather than replacing platelets directly, the medication works by activating biological pathways involved in platelet production.

Clinically Established Therapy

Eltrombopag has been extensively studied for the management of various thrombocytopenia-related conditions.

Benefits of Revolade 25 mg

• Helps increase platelet production in eligible patients

• Supports improved blood clotting function

• May reduce the risk of bleeding episodes associated with low platelet counts

• Provides an oral treatment option

• Can assist in maintaining platelet levels over time

• May help reduce dependence on repeated platelet transfusions in some cases

• Supports individualized treatment approaches for thrombocytopenia-related disorders

How to Take Revolade 25 mg

Revolade 25 mg should be taken exactly as prescribed by a healthcare provider.

The tablet is generally swallowed whole with water and should not be crushed or chewed unless specifically instructed by a physician. Patients are often advised to take the medication at the same time each day to maintain consistent drug levels in the body.

Because certain minerals and foods may affect absorption, healthcare providers may recommend specific timing instructions regarding meals, dairy products, calcium supplements, antacids, or mineral-containing products.

Following prescribed administration guidelines is essential for achieving optimal treatment outcomes.

Dosage Considerations

The appropriate dosage of Revolade varies between individuals and depends on several factors, including:

• Age

• Body weight

• Platelet count

• Underlying medical condition

• Liver function

• Response to treatment

• Concurrent medications

Regular blood tests are usually required to monitor platelet levels and determine whether dosage adjustments are necessary.

Patients should never modify their dose without consulting their healthcare provider.

Possible Side Effects

Like all medications, Revolade 25 mg may cause side effects, although not everyone experiences them.

Common Side Effects

• Headache

• Fatigue

• Nausea

• Muscle discomfort

• Joint pain

• Upper respiratory tract infections

• Diarrhea

• Loss of appetite

Less Common Side Effects

• Elevated liver enzyme levels

• Dizziness

• Abdominal discomfort

• Sleep disturbances

• Weakness

Serious Side Effects

Immediate medical attention may be required if symptoms such as the following occur:

• Signs of liver problems

• Severe allergic reactions

• Unusual blood clot formation

• Vision changes

• Significant swelling

• Severe bleeding symptoms

Any unusual or persistent symptoms should be reported to a healthcare professional promptly.

Precautions and Warnings

Before starting Revolade 25 mg, patients should inform their healthcare provider about their complete medical history.

Special caution may be required in individuals with:

• Liver disease

• History of blood clots

• Bone marrow disorders

• Cataracts

• Bleeding disorders

• Kidney impairment

• Cardiovascular disease

Routine monitoring helps healthcare providers identify potential complications early and ensure safe treatment continuation.

Drug Interactions

Revolade 25 mg may interact with various medications, supplements, and mineral-containing products.

Potential interactions may occur with:

• Antacids

• Calcium supplements

• Iron supplements

• Magnesium-containing products

• Zinc supplements

• Certain cholesterol-lowering medicines

• Some antiviral medications

Patients should provide a complete list of all prescription medicines, over-the-counter drugs, herbal products, and dietary supplements before beginning therapy.

Storage Instructions

Store Revolade 25 mg according to the instructions provided on the packaging.

General storage recommendations include:

• Keep at room temperature

• Protect from excessive heat and moisture

• Store in the original container

• Keep away from direct sunlight

• Keep out of reach of children and pets

Unused or expired medication should be disposed of according to local pharmaceutical disposal guidelines.

Who Should Not Use Revolade 25 mg?

Revolade may not be suitable for everyone. Healthcare providers carefully evaluate each patient's medical condition before prescribing this medication.

It may not be appropriate for:

• Individuals with known hypersensitivity to Eltrombopag or any tablet ingredient

• Patients with certain uncontrolled liver conditions

• Individuals with specific clotting disorders unless closely monitored

• Patients for whom the potential risks outweigh the expected benefits

Important Monitoring During Treatment

Treatment with Revolade 25 mg typically requires ongoing medical monitoring. Regular blood tests help evaluate platelet levels and assess treatment effectiveness. Liver function tests may also be performed because Eltrombopag can affect liver enzymes in some patients.

Consistent follow-up appointments allow healthcare providers to make informed decisions regarding dosage adjustments, treatment duration, and overall patient safety.